
### [MONDO:0015119](http://purl.obolibrary.org/obo/MONDO_0015119)
**Label:** rare bronchopulmonary tumor

**Subclasses:** [MONDO:0003805](http://purl.obolibrary.org/obo/MONDO_0003805) (malignant pericardial mesothelioma), [MONDO:0003128](http://purl.obolibrary.org/obo/MONDO_0003128) (classic pulmonary blastoma), [MONDO:0000532](http://purl.obolibrary.org/obo/MONDO_0000532) (lung combined type small cell adenocarcinoma), [MONDO:0017292](http://purl.obolibrary.org/obo/MONDO_0017292) (well-differentiated fetal adenocarcinoma of the lung), [MONDO:0003129](http://purl.obolibrary.org/obo/MONDO_0003129) (epithelial predominant pulmonary blastoma), [MONDO:0006378](http://purl.obolibrary.org/obo/MONDO_0006378) (pleural epithelioid mesothelioma), [MONDO:0006377](http://purl.obolibrary.org/obo/MONDO_0006377) (pleural biphasic mesothelioma), [MONDO:0011014](http://purl.obolibrary.org/obo/MONDO_0011014) (pleuropulmonary blastoma), [MONDO:0006292](http://purl.obolibrary.org/obo/MONDO_0006292) (malignant mesothelioma (disease)), [MONDO:0017288](http://purl.obolibrary.org/obo/MONDO_0017288) (dicer1 syndrome), [MONDO:0019963](http://purl.obolibrary.org/obo/MONDO_0019963) (bronchial endocrine tumor), [MONDO:0017289](http://purl.obolibrary.org/obo/MONDO_0017289) (fetal lung interstitial tumor), [MONDO:0008433](http://purl.obolibrary.org/obo/MONDO_0008433) (small cell lung carcinoma), [MONDO:0016570](http://purl.obolibrary.org/obo/MONDO_0016570) (primary pulmonary lymphoma), [MONDO:0020555](http://purl.obolibrary.org/obo/MONDO_0020555) (pleuropulmonary blastoma type 1), [MONDO:0003437](http://purl.obolibrary.org/obo/MONDO_0003437) (occult small cell lung carcinoma), [MONDO:0003438](http://purl.obolibrary.org/obo/MONDO_0003438) (combined small cell lung carcinoma), [MONDO:0006407](http://purl.obolibrary.org/obo/MONDO_0006407) (sarcomatoid mesothelioma), [MONDO:0020556](http://purl.obolibrary.org/obo/MONDO_0020556) (pleuropulmonary blastoma type 2), [MONDO:0020557](http://purl.obolibrary.org/obo/MONDO_0020557) (pleuropulmonary blastoma type 3), [MONDO:0004205](http://purl.obolibrary.org/obo/MONDO_0004205) (lymphohistiocytoid mesothelioma), [MONDO:0005933](http://purl.obolibrary.org/obo/MONDO_0005933) (pulmonary blastoma), [MONDO:0006109](http://purl.obolibrary.org/obo/MONDO_0006109) (malignant biphasic mesothelioma), [MONDO:0003436](http://purl.obolibrary.org/obo/MONDO_0003436) (lung oat cell carcinoma), [MONDO:0005512](http://purl.obolibrary.org/obo/MONDO_0005512) (malignant peritoneal mesothelioma), [MONDO:0002223](http://purl.obolibrary.org/obo/MONDO_0002223) (ovarian malignant mesothelioma), [MONDO:0005599](http://purl.obolibrary.org/obo/MONDO_0005599) (malignant epithelioid mesothelioma), [MONDO:0005112](http://purl.obolibrary.org/obo/MONDO_0005112) (malignant pleural mesothelioma), [MONDO:0006380](http://purl.obolibrary.org/obo/MONDO_0006380) (pleural sarcomatoid mesothelioma), 

**Mapped go classes:** [GO:0004386](http://purl.obolibrary.org/obo/GO_0004386) (helicase activity), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0032449](http://purl.obolibrary.org/obo/GO_0032449) (CBM complex), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0016891](http://purl.obolibrary.org/obo/GO_0016891) (endoribonuclease activity, producing 5'-phosphomonoesters), [GO:0070883](http://purl.obolibrary.org/obo/GO_0070883) (pre-miRNA binding), [GO:0072149](http://purl.obolibrary.org/obo/GO_0072149) (glomerular visceral epithelial cell fate commitment), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0030422](http://purl.obolibrary.org/obo/GO_0030422) (production of siRNA involved in RNA interference), [GO:0035279](http://purl.obolibrary.org/obo/GO_0035279) (mRNA cleavage involved in gene silencing by miRNA), [GO:0030423](http://purl.obolibrary.org/obo/GO_0030423) (targeting of mRNA for destruction involved in RNA interference), [GO:0035195](http://purl.obolibrary.org/obo/GO_0035195) (gene silencing by miRNA), [GO:0035196](http://purl.obolibrary.org/obo/GO_0035196) (production of miRNAs involved in gene silencing by miRNA), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0042101](http://purl.obolibrary.org/obo/GO_0042101) (T cell receptor complex), [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0032835](http://purl.obolibrary.org/obo/GO_0032835) (glomerulus development), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0016442](http://purl.obolibrary.org/obo/GO_0016442) (RISC complex), [GO:0050767](http://purl.obolibrary.org/obo/GO_0050767) (regulation of neurogenesis), [GO:0035068](http://purl.obolibrary.org/obo/GO_0035068) (micro-ribonucleoprotein complex), [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:0039022](http://purl.obolibrary.org/obo/GO_0039022) (pronephric duct development), [GO:0061032](http://purl.obolibrary.org/obo/GO_0061032) (visceral serous pericardium development), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0039021](http://purl.obolibrary.org/obo/GO_0039021) (pronephric glomerulus development), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0031054](http://purl.obolibrary.org/obo/GO_0031054) (pre-miRNA processing), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0006396](http://purl.obolibrary.org/obo/GO_0006396) (RNA processing), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0004530](http://purl.obolibrary.org/obo/GO_0004530) (deoxyribonuclease I activity), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0004525](http://purl.obolibrary.org/obo/GO_0004525) (ribonuclease III activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0046696](http://purl.obolibrary.org/obo/GO_0046696) (lipopolysaccharide receptor complex), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0072112](http://purl.obolibrary.org/obo/GO_0072112) (glomerular visceral epithelial cell differentiation), [GO:0031047](http://purl.obolibrary.org/obo/GO_0031047) (gene silencing by RNA), [GO:0070578](http://purl.obolibrary.org/obo/GO_0070578) (RISC-loading complex), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 52.93%
- [GO:0098795](http://purl.obolibrary.org/obo/GO_0098795) (mRNA cleavage involved in gene silencing) 52.38%
- [GO:0070918](http://purl.obolibrary.org/obo/GO_0070918) (production of small RNA involved in gene silencing by RNA) 52.38%
- [GO:0070578](http://purl.obolibrary.org/obo/GO_0070578) (RISC-loading complex) 52.38%
- [GO:0061032](http://purl.obolibrary.org/obo/GO_0061032) (visceral serous pericardium development) 52.38%
- [GO:0046696](http://purl.obolibrary.org/obo/GO_0046696) (lipopolysaccharide receptor complex) 52.38%
- [GO:0039022](http://purl.obolibrary.org/obo/GO_0039022) (pronephric duct development) 52.38%
- [GO:0039021](http://purl.obolibrary.org/obo/GO_0039021) (pronephric glomerulus development) 52.38%
- [GO:0035279](http://purl.obolibrary.org/obo/GO_0035279) (mRNA cleavage involved in gene silencing by miRNA) 52.38%
- [GO:0035196](http://purl.obolibrary.org/obo/GO_0035196) (production of miRNAs involved in gene silencing by miRNA) 52.38%
- [GO:0035195](http://purl.obolibrary.org/obo/GO_0035195) (gene silencing by miRNA) 52.38%
- [GO:0035194](http://purl.obolibrary.org/obo/GO_0035194) (posttranscriptional gene silencing by RNA) 52.38%
- [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex) 52.38%
- [GO:0035068](http://purl.obolibrary.org/obo/GO_0035068) (micro-ribonucleoprotein complex) 52.38%
- [GO:0032835](http://purl.obolibrary.org/obo/GO_0032835) (glomerulus development) 52.38%


